Financial News
Latest News about VRTX
Recent news which mentions VRTX
A Deep Dive Into the Video Game Industry
January 29, 2022
From Motley Fool
3 Growth ETFs to Consider Buying During This Correction
January 29, 2022
From Motley Fool
Market Dip? Here's Why This Bargain Biotech Is a Smart Buy Now
January 28, 2022
From Motley Fool
The Smartest Stocks to Buy With $500 in 2022
January 28, 2022
From Motley Fool
Vertex Pharmaceuticals (VRTX) Q4 2021 Earnings Call Transcript
January 27, 2022
Tickers
VRTX
From Motley Fool
From Motley Fool
The Daily Biotech Pulse: Gilead's Blood Cancer Studies Placed On Partial Clinical Hold, Immunocore Gets FDA Nod, NRx Touts Positive COVID-19 Data
January 26, 2022
From Benzinga
3 Green Flags for CRISPR Therapeutics' Future
January 26, 2022
From Motley Fool
Earnings Scheduled For January 26, 2022
January 26, 2022
From Benzinga
2 No-Brainer Healthcare Stocks to Buy Right Now
January 25, 2022
From Motley Fool
Rule Breaker Investing: Essays From Yesterday Volume 3
January 24, 2022
From Motley Fool
Is CRISPR Therapeutics a Buy?
January 24, 2022
From Motley Fool
3 Unstoppable Biotech Stocks to Buy Right Now
January 24, 2022
From Motley Fool
The Week Ahead In Biotech (Jan 23-29): Roche, Azurity FDA Decisions, J&J, Vertex Earnings, Samsara Vision IPO And More
January 23, 2022
From Benzinga
3 Clinical Trials to Watch in the First Half of 2022
January 22, 2022
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For January 20, 2022
January 20, 2022
From Benzinga
10 Biggest Price Target Changes For Thursday
January 20, 2022
From Benzinga
4 Unstoppable Stocks That Can Run Circles Around Shiba Inu in 2022
January 19, 2022
From Motley Fool
Buy These Stocks If You Want 126% to 206% Returns, Says Wall Street
January 18, 2022
From Motley Fool
Is Beam Therapeutics a Good Stock to Buy Now?
January 16, 2022
From Motley Fool
3 Cathie Wood Stocks That Could Deliver Bigger Gains Than the Market
January 16, 2022
From Motley Fool
From Benzinga
4 Biotech Acquisitions We'd Like to See in 2022
January 14, 2022
From Motley Fool
The Top Stocks These Investors Plan on Buying Soon
January 10, 2022
From Motley Fool
3 No-Brainer Big Pharma Stocks to Buy in 2022
January 09, 2022
From Motley Fool
Better Buy: Vertex Pharmaceuticals vs. Biogen
January 07, 2022
From Motley Fool
A Bullish Sign Appears On Vertex Pharmaceuticals's Chart
January 06, 2022
Tickers
VRTX
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.